20 Best Performing Stocks in 2025

Page 16 of 18

3. Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Total Returns in 2025: 629.2% 

Number of Hedge Fund Holders: 29

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the Best Performing Stocks.

On December 11, 2025, TheFly reported that Citizens boosted its price goal for Terns Pharmaceuticals, Inc. (NASDAQ:TERN) to $57 from $35. The firm retained an Outperform rating, noting interim Phase 1 CARDINAL ASH data confirming a best-in-class profile for TERN-701. The firm identified strong activity after asciminib and ponatinib, which it considers favorable for second-line use, and a high deep molecular response rate that supports first-line potential.

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) released third-quarter 2025 results and corporate updates, pointing out that an ASH 2025 abstract featured unprecedented Phase 1 CML efficacy data and a possible best-in-disease profile for TERN-701. An expanded and updated CARDINAL dataset is anticipated to be included in an upcoming ASH oral presentation.

Separately, the firm reported $295.6 million in cash, cash equivalents, and marketable securities as of September 30, 2025, down from $358.2 million as of December 31, 2024. The company stated that current funds are anticipated to cover planned operating costs until 2028.

Nonetheless, the stock is down by 3.07% as of January 6, 2026.

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is a clinical-stage biopharmaceutical business.

Page 16 of 18